Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612412 · ClinicalTrials.gov registry record · NA
Exercise for Better Bones - Day or Night?
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05612412: Clinical Trial NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT05612412 is a NA study that was terminated before completion, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05612412, a NA study, was terminated before completion, sponsored by USDA Grand Forks Human Nutrition Research Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if moderate exercise at different time during the day (early morning vs early evening) affects biomarker CTX of bone health in normal to overweight postmenopausal women.
Primary Outcome
Test the differences in morning peak serum CTX following one bout of exercise per day for 10 days over a two-week period in either the early morning or the evening.
Interventions
- OTHER Morning Exercise
- OTHER Evening Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2024-07-30 |
| Phase | NA |
Why NCT05612412 stopped before completion
NCT05612412 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Morning Exercise is the first listed.
NCT05612412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05612412 about?
NCT05612412 is a clinical study titled "Exercise for Better Bones - Day or Night?". The purpose of this study is to find out if moderate exercise at different time during the day (early morning vs early evening) affects biomarker CTX of bone health in normal to overweight postmenopausal women.
What is the current status of trial NCT05612412?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-10-05. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT05612412?
The interventions under investigation include: Morning Exercise (OTHER), Evening Exercise (OTHER).
Who is sponsoring clinical trial NCT05612412?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05612412's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI